Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1).
about
New Strategies for the Treatment of Solid Tumors with CAR-T CellsMesenchymal Stromal Cells Can Regulate the Immune Response in the Tumor MicroenvironmentFibroblast activation protein α in tumor microenvironment: recent progression and implications (review)Driving CAR T-cells forwardChimeric antigen receptor T cells: a novel therapy for solid tumors.Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells.Searching for targets for the systemic therapy of mesothelioma.Chimeric Antigen Receptor (CAR) T Cell Therapy for Malignant Pleural Mesothelioma (MPM).Prospects for adoptive immunotherapy of pancreatic cancer using chimeric antigen receptor-engineered T-cells.CAR T-cell immunotherapy: The path from the by-road to the freeway?Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors?Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells.CAR T-cell therapy for lung cancer and malignant pleural mesothelioma.Harnessing the immune response to target tumors.Clinical development of CAR T cells-challenges and opportunities in translating innovative treatment conceptsChimeric antigen receptor T cell (CAR-T) immunotherapy for solid tumors: lessons learned and strategies for moving forward.How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive.Synthetic immunology: T-cell engineering and adoptive immunotherapy
P2860
Q26748500-5252965E-E873-4D4D-8807-493FE4225EBBQ28073613-28902424-3281-4E04-BD8B-8CA3E10E4375Q28082504-CA15E03D-BAFC-4791-BC3B-5A4C085BB221Q34046505-B0568975-0245-46BB-90CE-5411E5769865Q37728639-50243D1E-4929-40C8-8BD2-9E718D670F0CQ38170500-DAFD95FB-3A09-46FF-A70F-2B2A71718206Q38365768-D9FCB509-61F4-434B-9743-E6EF916298ABQ38399051-6C472211-630B-48C5-92BC-92B5194ADBBDQ38608986-3096E2A3-5F7D-4959-B174-56A3AC98A4E8Q38632105-95A74D30-DC5D-4E03-AA9B-B771E9D3C3E9Q38795935-419E430E-EAC2-4CE2-9C40-C84D1086ACB1Q39111432-662D7648-DEFB-4050-9EB7-5FCE962C557EQ39305346-7863FC3C-45A9-46B3-9D45-8D2A974A48EAQ39377265-06EB83D6-E653-4863-A57E-FA7A06B0F1B7Q41600980-F3C51118-2652-432F-B0E3-EEE5740FF57FQ49280922-07B85B28-A5E2-46A3-868F-0EA4B69C2D75Q52668325-6D878B2F-B014-403A-A343-8213C3038A49Q57823195-AC7C7381-7FE7-4993-9E8E-EF4102DA50D1
P2860
Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1).
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Re-directed T cells for the tr ...... leural mesothelioma (FAPME-1).
@ast
Re-directed T cells for the tr ...... leural mesothelioma (FAPME-1).
@en
Re-directed T cells for the treatment of fibroblast activation protein
@nl
type
label
Re-directed T cells for the tr ...... leural mesothelioma (FAPME-1).
@ast
Re-directed T cells for the tr ...... leural mesothelioma (FAPME-1).
@en
Re-directed T cells for the treatment of fibroblast activation protein
@nl
prefLabel
Re-directed T cells for the tr ...... leural mesothelioma (FAPME-1).
@ast
Re-directed T cells for the tr ...... leural mesothelioma (FAPME-1).
@en
Re-directed T cells for the treatment of fibroblast activation protein
@nl
P2093
P2860
P356
P1433
P1476
Re-directed T cells for the tr ...... leural mesothelioma (FAPME-1).
@en
P2093
Alex Soltermann
Christian Hagedorn
Christoph Renner
Petra C Schuberth
Rolf Stahel
Sandra Tomaszek
Ulf Petrausch
Walter Weder
P2860
P2888
P356
10.1186/1471-2407-12-615
P407
P577
2012-12-22T00:00:00Z
P5875
P6179
1020556266